MassMutual Private Wealth & Trust’s Rhythm Pharmaceuticals RYTM Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio RYTM Stock Details RYTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$111	Buy	+1	New	+$90	﹤0.01%	2382

Other funds holding RYTM

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Aspiriant LLC Los Angeles, California $4.05B AUM 19.01% 1-Year Est. Return

WCM

Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

KOCAA

Knights of Columbus Asset Advisors New Haven, Connecticut $2B AUM 42.86% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

MassMutual Private Wealth & Trust's RYTM Position: Q2 2026 in Review

MassMutual Private Wealth & Trust opened a new position in Rhythm Pharmaceuticals (RYTM) in Q2 2026: 1 share worth $111. The stake represents ﹤0.01% of the portfolio and ranks #2382 among its holdings.

57 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

MassMutual Private Wealth & Trust held 1 share of Rhythm Pharmaceuticals worth $111 as of Q2 2026.
Rhythm Pharmaceuticals was a new MassMutual Private Wealth & Trust position in Q2 2026.
Rhythm Pharmaceuticals made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q2 2026, its #2382 holding.
57 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2026, filed 2 Jul 2026.